Literature DB >> 15243697

Social exclusion in clients with comorbid mental health and substance misuse problems.

J Todd1, G Green, M Harrison, B A Ikuesan, C Self, D J Pevalin, A Baldacchino.   

Abstract

BACKGROUND: The concept of comorbid mental health problems and substance misuse has gained prominence in the last two decades, due in part to the closure of large psychiatric hospitals and to the increasing prevalence of drug use in the community. This client group has a dual requirement for both medical and social care needs and is at risk for social exclusion.
METHODS: A retrospective matched case-control study to examine aspects of social exclusion between service users who have comorbid diagnoses and those with a single diagnosis. Samples were drawn from the service users of a mental health Trust in the South-East of England, from both Adult Mental Health (n = 400) and Drug and Alcohol services (n = 190). Data were collected from Care Programme Approach assessment forms and medical records. McNemar's chi(2) and odds ratios via a conditional logit regression model are used to test for differences in the social exclusion indicators.
RESULTS: There were significant differences in social exclusion between the comorbid and singly diagnosed clients of the Adult Mental Health service, but differences were less pronounced between the comorbid and singly diagnosed clients of the specialist Drug and Alcohol service.
CONCLUSIONS: Recent Government policy advocates treating comorbid clients within mainstream mental health services. Health care workers need to recognise the likelihood of high levels of social exclusion among clients with comorbid problems.

Entities:  

Mesh:

Year:  2004        PMID: 15243697     DOI: 10.1007/s00127-004-0790-0

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  8 in total

1.  Social exclusion of people with severe mental illness in Switzerland: results from the Swiss Health Survey.

Authors:  D Richter; H Hoffmann
Journal:  Epidemiol Psychiatr Sci       Date:  2017-12-13       Impact factor: 6.892

2.  The Effectiveness of Supported Employment in People With Dual Disorders.

Authors:  Kim T Mueser; Kikuko Campbell; Robert E Drake
Journal:  J Dual Diagn       Date:  2011-05-11

3.  Alcohol and smoking consumption behaviours in older Australian adults: prevalence, period and socio-demographic differentials in the DYNOPTA sample.

Authors:  Richard A Burns; Carole L Birrell; David Steel; Paul Mitchell; Kaarin J Anstey
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-08-10       Impact factor: 4.328

4.  Social Support Networks and Symptom Severity Among Patients with Co-occurring Mental Health and Substance Use Disorders.

Authors:  Marie C Haverfield; Mark Ilgen; Eric Schmidt; Alexandra Shelley; Christine Timko
Journal:  Community Ment Health J       Date:  2019-03-12

Review 5.  Work, recovery, and comorbidity in schizophrenia: a randomized controlled trial of cognitive remediation.

Authors:  Susan R McGurk; Kim T Mueser; Thomas J DeRosa; Rosemarie Wolfe
Journal:  Schizophr Bull       Date:  2009-03-05       Impact factor: 9.306

6.  Models of Concurrent Disorder Service: Policy, Coordination, and Access to Care.

Authors:  Mary Wiktorowicz; Aber Abdulle; Kaitlin Di Pierdomenico; Sheila A Boamah
Journal:  Front Psychiatry       Date:  2019-02-19       Impact factor: 4.157

Review 7.  Everyday Lives of Middle-Aged Persons with Multimorbidity: A Mixed Methods Systematic Review.

Authors:  Ana Isabel González-González; Robin Brünn; Julia Nothacker; Christine Schwarz; Edris Nury; Truc Sophia Dinh; Maria-Sophie Brueckle; Mirjam Dieckelmann; Beate Sigrid Müller; Marjan van den Akker
Journal:  Int J Environ Res Public Health       Date:  2021-12-21       Impact factor: 3.390

8.  "You Never Know What Happens Next" - Young Adult Service Users' Experience with Mental Health Care and Treatment through One Year.

Authors:  Marian Ådnanes; Sissel Steihaug
Journal:  Int J Integr Care       Date:  2016-07-22       Impact factor: 5.120

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.